石家庄龙泽制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
15
NMPA:15
Drug Approvals
Vortioxetine Hydrobromide Tablets
- Product Name
- 氢溴酸伏硫西汀片
- Approval Number
- 国药准字H20253149
- Approval Date
- Jan 14, 2025
NMPA
Esomeprazole Magnesium Enteric-coated Tablets
- Product Name
- 艾司奥美拉唑镁肠溶片
- Approval Number
- 国药准字H20249410
- Approval Date
- Nov 15, 2024
NMPA
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅱ ）
- Product Name
- 恩曲他滨丙酚替诺福韦片(Ⅱ)
- Approval Number
- 国药准字H20243934
- Approval Date
- Jul 23, 2024
NMPA
Tenofovir Disoproxil Fumarate
- Product Name
- 富马酸替诺福韦二吡呋酯
- Approval Number
- 国药准字H20173158
- Approval Date
- Apr 12, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found